Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genome-scale CRISPR screen reveals neddylation to contribute to cisplatin resistance of testicular germ cell tumours
Kai Funke, Ulf Einsfelder, Aylin Hansen, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 12, pp. 2270-2282
Open Access | Times Cited: 12

Showing 12 citing articles:

CRISPR-Cas and CRISPR-based screening system for precise gene editing and targeted cancer therapy
Mingming Qin, Chunhao Deng, Liewei Wen, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Neddylation activated TRIM25 desensitizes triple-negative breast cancer to paclitaxel via TFEB-mediated autophagy
Bowen Zheng, Fengyuan Qian, Xuehui Wang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 4
TRIM25: A Global Player of Cell Death Pathways and Promising Target of Tumor-Sensitizing Therapies
W. Eberhardt, Usman Nasrullah, Josef Pfeilschifter
Cells (2025) Vol. 14, Iss. 2, pp. 65-65
Open Access
Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors and potential therapeutic agents (Review)
Ziqing Zhan, Xia Luo, Jiaxin Shi, et al.
Experimental and Therapeutic Medicine (2025) Vol. 29, Iss. 4, pp. 1-15
Open Access
Integrative analysis based on CRISPR screen identifies apilimod as a potential therapeutic agent for cisplatin-induced acute kidney injury treatment
Yunpeng Chu, Muyun Wei, Zhongyu Cao, et al.
Science China Life Sciences (2025)
Closed Access
BRD9 inhibition as potential treatment option for testicular germ cell tumors
Aylin Hansen, Christine Sanders, Florian Fronhoffs, et al.
Andrology (2025)
Open Access
Biomarkers for Salvage Therapy in Testicular Germ Cell Tumors
Milena Urbini, Sara Bleve, Giuseppe Schepisi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16872-16872
Open Access | Times Cited: 6
A Transcriptomic comparison of in vitro models of the human placenta
Samantha Lapehn, S.K. Nair, Evan J. Firsick, et al.
Placenta (2024) Vol. 159, pp. 52-61
Open Access | Times Cited: 1
Phosphatidic acid as a cofactor of mTORC1 in platinum-based chemoresistance: mechanisms and therapeutic potential
Hamideh Alizadeh, Sana Kerachian, Keyvan Jabbari, et al.
European Journal of Pharmacology (2024), pp. 177220-177220
Closed Access | Times Cited: 1
“Pass the Genetic Scalpel”: A Comprehensive Review of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) in Urological Cancers
Arthur Yim, Matthew Alberto, Marco J. Herold, et al.
Société Internationale d’Urologie Journal (2024) Vol. 5, Iss. 1, pp. 16-30
Open Access
Transcriptomic comparison of in vitro models of the human placenta
Samantha Lapehn, S.K. Nair, Evan J. Firsick, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
LINC00470 promotes malignant progression of testicular germ cell tumors
Zhizhong Liu, Shanshan Lv, Zailong Qin, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access
Page 1

Scroll to top